Alerts will be sent to your verified email
Verify Email
SOTAC
|
Sotac Pharmaceutical
|
Krebs Biochem.&Inds
|
Godavari Drugs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
16.56 % | 37.05 % | 14.06 % |
|
5yr average Equity Multiplier
|
5.52 | -2.13 | 3.51 |
|
5yr Average Asset Turnover Ratio
|
1.27 | 0.3 | 1.24 |
|
5yr Avg Net Profit Margin
|
3.04 % | -55.19 % | 3.28 % |
|
Price to Book
|
0.0 | 0.0 | 2.8 |
|
P/E
|
15.32 | 0.0 | 34.44 |
|
5yr Avg Cash Conversion Cycle
|
57.86 Days | -1144.52 Days | 107.21 Days |
|
Inventory Days
|
44.94 Days | 102.59 Days | 47.15 Days |
|
Days Receivable
|
113.65 Days | 8.23 Days | 163.82 Days |
|
Days Payable
|
123.13 Days | 623.06 Days | 106.32 Days |
|
5yr Average Interest Coverage Ratio
|
3.95 | -4.97 | 2.61 |
|
5yr Avg ROCE
|
21.68 % | -23.43 % | 20.07 % |
|
5yr Avg Operating Profit Margin
|
8.59 % | -34.39 % | 8.03 % |
|
5 yr average Debt to Equity
|
2.1 | -1.88 | 1.34 |
|
5yr CAGR Net Profit
|
n/a | -0.84 % | 1.18 % |
|
5yr Average Return on Assets
|
3.18 % | -16.47 % | 4.0 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.85 % | 72.74 % | 40.23 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.21 % |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -12.89 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.99 % |
|
Sotac Pharmaceutical
|
Krebs Biochem.&Inds
|
Godavari Drugs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|